United States
# |
Name |
Gross Profit Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
49,020.46%
|
Sept. 30, 2024 | USD 7.90 | 0.64% |
|
United States |
|
2 |
177.80%
|
Sept. 30, 2024 | USD 6.52 | -5.10% |
|
United States |
|
3 |
174.11%
|
Sept. 30, 2024 | USD 39.35 | 5.02% |
|
United States |
|
4 |
143.86%
|
Sept. 30, 2024 | USD 238.00 | 2.46% |
|
United States |
|
5 |
136.06%
|
Sept. 30, 2024 | USD 13.06 | 2.75% |
|
United States |
|
6 |
132.84%
|
Sept. 30, 2024 | USD 36.01 | 1.84% |
|
United States |
|
7 |
130.45%
|
Sept. 30, 2024 | USD 60.55 | 4.36% |
|
United States |
|
8 |
129.85%
|
Sept. 30, 2024 | USD 96.46 | 4.52% |
|
United States |
|
9 |
128.33%
|
Sept. 30, 2024 | USD 7.16 | -3.63% |
|
United States |
|
10 |
127.19%
|
Sept. 30, 2024 | USD 31.25 | 4.52% |
|
United States |
|
11 |
126.84%
|
Sept. 30, 2024 | USD 23.10 | 2.03% |
|
United States |
|
12 |
126.60%
|
Sept. 30, 2024 | USD 20.91 | 0.38% |
|
United States |
|
13 |
125.75%
|
Sept. 30, 2024 | USD 17.60 | 4.95% |
|
United States |
|
14 |
123.92%
|
Sept. 30, 2024 | USD 14.70 | 1.38% |
|
United States |
|
15 |
122.82%
|
Sept. 30, 2024 | USD 27.70 | 1.76% |
|
United States |
|
16 |
122.74%
|
Sept. 30, 2024 | USD 34.10 | 2.16% |
|
United States |
|
17 |
121.61%
|
Sept. 30, 2024 | USD 25.88 | 4.27% |
|
United States |
|
18 |
121.07%
|
Sept. 30, 2024 | USD 117.97 | 4.36% |
|
United States |
|
19 |
120.59%
|
Sept. 30, 2024 | USD 56.46 | 2.95% |
|
United States |
|
20 |
117.33%
|
Sept. 30, 2024 | USD 10.83 | 1.21% |
|
United States |
|
21 |
117.05%
|
Sept. 30, 2024 | USD 24.68 | 3.09% |
|
United States |
|
22 |
116.99%
|
Sept. 30, 2024 | USD 24.46 | 4.31% |
|
United States |
|
23 |
116.86%
|
Sept. 30, 2024 | USD 48.95 | 2.23% |
|
United States |
|
24 |
116.62%
|
Sept. 30, 2024 | USD 10.17 | 5.72% |
|
United States |
|
25 |
116.25%
|
Sept. 30, 2024 | USD 34.76 | 3.67% |
|
United States |
|
26 |
115.65%
|
Sept. 30, 2024 | USD 9.86 | 3.46% |
|
United States |
|
27 |
115.65%
|
Sept. 30, 2024 | USD 15.72 | 3.15% |
|
United States |
|
28 |
115.34%
|
Sept. 30, 2024 | USD 83.58 | 4.62% |
|
United States |
|
29 |
114.94%
|
Sept. 30, 2024 | USD 9.11 | 4.11% |
|
United States |
|
30 |
114.75%
|
Sept. 30, 2024 | USD 20.88 | 1.90% |
|
United States |
|
31 |
114.49%
|
Sept. 30, 2024 | USD 15.56 | 3.53% |
|
United States |
|
32 |
114.29%
|
Sept. 30, 2024 | USD 2.73 | 10.08% |
|
United States |
|
33 |
113.37%
|
Sept. 30, 2024 | USD 18.24 | 2.99% |
|
United States |
|
34 |
113.10%
|
Sept. 30, 2024 | USD 32.12 | 2.62% |
|
United States |
|
35 |
112.98%
|
Sept. 30, 2024 | USD 15.50 | 0.85% |
|
United States |
|
36 |
112.94%
|
Sept. 30, 2024 | USD 15.14 | 1.88% |
|
United States |
|
37 |
112.88%
|
Sept. 30, 2024 | USD 13.49 | 7.06% |
|
United States |
|
38 |
112.47%
|
Sept. 30, 2024 | USD 84.94 | 3.56% |
|
United States |
|
39 |
112.36%
|
Sept. 30, 2024 | USD 28.97 | 3.17% |
|
United States |
|
40 |
112.36%
|
Sept. 30, 2024 | USD 19.28 | 3.10% |
|
United States |
|
41 |
112.32%
|
Sept. 30, 2024 | USD 11.73 | 2.71% |
|
United States |
|
42 |
112.28%
|
Sept. 30, 2024 | USD 42.81 | 4.52% |
|
United States |
|
43 |
112.03%
|
Sept. 30, 2024 | USD 51.37 | 3.61% |
|
United States |
|
44 |
111.74%
|
Sept. 30, 2024 | USD 97.34 | 4.76% |
|
United States |
|
45 |
111.64%
|
Sept. 30, 2024 | USD 9.24 | 1.32% |
|
United States |
|
46 |
111.49%
|
Sept. 30, 2024 | USD 29.74 | 5.50% |
|
United States |
|
47 |
110.98%
|
Sept. 30, 2024 | USD 5.81 | 7.00% |
|
United States |
|
48 |
110.89%
|
Sept. 30, 2024 | USD 15.15 | 2.43% |
|
United States |
|
49 |
110.79%
|
Sept. 30, 2024 | USD 42.89 | 2.78% |
|
United States |
|
50 |
110.39%
|
Sept. 30, 2024 | USD 31.40 | 3.94% |
|
United States |
The company in United States with the highest Gross Profit Margin is Bogota Financial Corp. (NasdaqCM: BSBK) at 49,020.46%.
The company in United States with the lowest Gross Profit Margin is Inhibikase Therapeutics, Inc. (NasdaqCM: IKT) at -1,970,400.00%.
The top 10 companies in United States by Gross Profit Margin are Bogota Financial Corp., Avalo Therapeutics, Inc., Live Oak Bancshares, Inc., Hingham Institution for Savings, Bridgewater Bancshares, Inc., Merchants Bancorp, Burke & Herbert Bank & Trust Company, Northeast Bank, Summit State Bank and Dime Community Bancshares, Inc..
The bottom 10 companies in United States by Gross Profit Margin are Inhibikase Therapeutics, Inc., DatChat, Inc., Allogene Therapeutics, Inc., Checkpoint Therapeutics, Inc., NET Power Inc., Aqua Metals, Inc., ICC Holdings, Inc., Mercantile Bank Corporation, Revolution Medicines, Inc. and Stewart Information Services Corporation.